HOOKIPA Pharma Inc. (HOOK)
NASDAQ: HOOK · Real-Time Price · USD
1.895
-0.135 (-6.65%)
Dec 24, 2024, 4:00 PM EST - Market closed
HOOKIPA Pharma Stock Forecast
HOOK's stock price has decreased by -73.68% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 4 analysts with 12-month price forecasts for HOOKIPA Pharma stock have an average target of 23, with a low estimate of 2.00 and a high estimate of 60. The average target predicts an increase of 1,113.72% from the current stock price of 1.90.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for HOOKIPA Pharma stock from 4 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 1 | 1 |
| Buy | 2 | 3 | 3 | 3 | 3 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 5 | 5 | 5 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Buy → Hold Downgrades $48 → $2 | Buy → Hold | Downgrades | $48 → $2 | +5.54% | Dec 20, 2024 |
| JMP Securities | JMP Securities | Buy Maintains $24 → $7 | Buy | Maintains | $24 → $7 | +269.39% | Nov 21, 2024 |
| RBC Capital | RBC Capital | Buy Maintains $50 → $48 | Buy | Maintains | $50 → $48 | +2,432.98% | Nov 15, 2024 |
| JMP Securities | JMP Securities | Buy Maintains $23 → $24 | Buy | Maintains | $23 → $24 | +1,166.49% | Aug 9, 2024 |
| JMP Securities | JMP Securities | Buy Maintains $50 → $23 | Buy | Maintains | $50 → $23 | +1,113.72% | Jul 26, 2024 |
Financial Forecast
Revenue This Year
49.82M
from 20.13M
Increased by 147.52%
Revenue Next Year
25.50M
from 49.82M
Decreased by -48.82%
EPS This Year
-1.59
from -8.63
EPS Next Year
-4.00
from -1.59
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 55.7M | 26.3M | 2.6M | |||
| Avg | 49.8M | 25.5M | 2.6M | |||
| Low | 43.7M | 24.5M | 2.5M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 176.9% | -47.3% | -89.7% | |||
| Avg | 147.5% | -48.8% | -90.0% | |||
| Low | 117.1% | -50.8% | -90.4% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | -0.70 | -1.99 | -8.89 | |||
| Avg | -1.59 | -4.00 | -8.64 | |||
| Low | -2.39 | -5.82 | -8.30 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | - | - | |||
| Avg | - | - | - | |||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.